Contributors
Latest:
An Expert Looks to the Future of Metastatic Kidney Cancer TreatmentDr. Toni K. Choueiri discusses what therapies are currently available for patients with metastatic renal cell carcinoma, as well as what new treatments could be on the horizon.
Latest:
Doctor Reflects on 30 Years of Cancer HistoryWhen I began my medical oncology career more than 30 years ago, I was determined to be among the first generation of researchers to cure cancer.
Latest:
Survivor GuiltLatest:
Learning to Speak Up With CancerWhat stands in the way of patient-physician communications and how can we get around these barriers?
Latest:
Embracing Multitasking: Combining Treatments for Pancreatic CancerAn expert sheds light on emerging combination treatments for pancreatic cancer.
Latest:
NORD Offers Information and Support for Patients of Rare CancersNORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer.
Latest:
Expanding Definition of Cancer Survivorship Highlights Need for New StandardsTara Sweeney, BSN, RN, OCN, CHPN discussed best care for the health and well-being of a person across all stages of their cancer survivorship.
Latest:
Mark R. Gilbert Discusses Glioblastoma ResearchCURE spoke with Gilbert at the 2015 Society for Neuro-Oncology Annual Meeting, a meeting of over 1,000 oncology professionals.
Latest:
Getting Warmer: Women Can Revive Sexual Function After CancerCancer can put a damper on women's sex life, but thanks to therapy and new medical treatments, they can get back to being intimate again.
Latest:
My Oncology Nurse, the Sunshine in My LifeAn Extraordinary Healer essay honoring ADRIANA TAURIELLO-WISE, RN, OCN [THE CANCER INSTITUTE AT ST. FRANCIS HOSPITAL, EAST HILL, NEW YORK]
Latest:
Getting to the Root of Financial Toxicity in Colorectal CancerIn colorectal and other cancers, financial burden is worsened by expensive drugs, long-term treatment and sharing of insurance costs.
Latest:
The Connection Between Lung Cancer and Outdoor Air PollutionOverwhelming evidence shows that particle pollution in the outdoor air we breathe — like that coming from vehicle exhaust, coal-fired power plants and other industrial sources — can cause lung cancer.
Latest:
Who Will Reduce Barriers to Cancer Care?An Extraordinary Healer essay honoring MARY SMANIA, D.N.P., FNP-BC, AGN-BC [ASSISTANT PROFESSOR, HEALTH PROGRAMS, MICHIGAN STATE UNIVERSITY COLLEGE OF NURSING, LIFE SCIENCE, LANSING, MICHIGAN]
Latest:
William G. Wierda on the Treatment of CLLCURE spoke with Wierda at the 2015 Chemotherapy Foundation Symposium, a meeting of over 1,000 oncologists and oncology professionals.
Latest:
Patrick I. Borgen on Cancer-Related Pain Relief With ExparelPatrick I. Borgen, chair, Department of Surgery, director, Maimonides Breast Cancer Center, provides an overview of cancer-related pain relief with Exparel.
Latest:
Patients Unable to Work May Qualify for Disability BenefitsIf you've been diagnosed with cancer, cannot work due to your symptoms and expect to remain in that situation for more than 12 months, the Social Security Administration may be able to offer you disability benefits.
Latest:
Contagious EnthusiasmOncolytic, or engineered, viruses that infect and kill cancer cells are showing promise.
Latest:
Implementing Standards of Care in Radiation Dermatitis PreventionAn Extraordinary Healer essay honoring ANNA SKRIPNIK LUCAS, M.S.N., RN, DNC, FNP-BC [MEMORIAL SLOAN KETTERING CANCER CENTER, NEW YORK, NEW YORK]
Latest:
Raghav Sundar on Preventing CIPNRaghav Sundar, M.B.B.S., M.R.C.P., M.Med., National University Health System in Singapore, discusses the possibility of cooling limbs during chemotherapy infusions to prevent chemotherapy-induced peripheral neuropathy. In a clinical trail of patients with breast cancer, this device showed proof of concept.
Latest:
Expert Discusses Side Effects of Keytruda That Patients with Hodgkin Lymphoma Should Know AboutData presented at the ASCO 2020 Virtual Scientific Program demonstrated that Keytruda was an effective treatment for patients with Hodgkin Lymphoma and side effects were tolerable.
Latest:
The Evolution of PARP Inhibitors in Ovarian CancerCristiana Sessa, M.D., of the Oncology Institute of Southern Switzerland, discusses the evolution of how PARP inhibitors are used to treat ovarian cancer.
Latest:
Chemobrain—It's Real, It's Complex, and the Science Is Still EvolvingTalk with almost any cancer survivor, and he or she is likely to bring up the topic of "chemobrain," that fuzzy, murky state that patients blame for impaired memory. A review of the research shows how we're focusing on the problem.
Latest:
Telehealth Can Expand Lung Cancer Treatment Options in Rural AreasRural patients tend to have diminished access to appropriate, routine cancer screening studies, leading to patients with cancer being diagnosed with more advanced stage disease.
Latest:
The Basics of Interventional Clinical TrialsAn expert describes what an interventional clinical trial is.
